Potential roles of follicular dendritic cell-associated osteopontin in lymphoid follicle pathology and repair and in B cell regulation in HIV-1 and SIV infection

Journal of Infectious Diseases

Volumn 192, Issue 7, 2005, Pages 1269-1276

  Li, Qingsheng ^a   Lifson, Jeffrey D ^d   Duan, Lijie ^a   Schacker, Timothy W ^b   Reilly, Cavan ^a   Carlis, John ^c   Estes, Jacob D ^a   Haase, Ashley T ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c University of Minnesota   (United States)

^d SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OSTEOPONTIN;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; BONE REMODELING; DNA MICROARRAY; FOLLICULAR DENDRITIC CELL; GENE EXPRESSION; GENE MAPPING; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNE RECONSTITUTION; IMMUNE RESPONSE; IMMUNOPATHOLOGY; LYMPH FOLLICLE; LYMPHOID TISSUE; MONKEY DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; SPECIES DIFFERENCE; TISSUE REPAIR; WOUND HEALING;

ANIMALS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; B-LYMPHOCYTES; BIOPSY; DENDRITIC CELLS, FOLLICULAR; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; LYMPH NODES; LYMPHOCYTE ACTIVATION; MACACA MULATTA; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEOPONTIN; SIALOGLYCOPROTEINS; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; SPECIES SPECIFICITY;

EID: 25444516852     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/444430     Document Type: Article

References (36)

1. Denhardt DT, Noda M, O'Regan AW, Pavlin D, Berman JS. Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. J Clin Invest 2001; 107:1055-61.
2. Gravallese EM. Osteopontin: a bridge between bone and the immune system. J Clin Invest 2003; 112:147-9.
3. Liaw L, Birk DE, Ballas CB, Whitsitt JS, Davidson JM, Hogan BLM. Altered wound healing in mice lacking a functional osteopontin gene (sppl). J Clin Invest 1998; 101:1468-78.
4. Speer MY, McKee MD, Guldberg RE, et al. Inactivation of the osteopontin gene enhances vascular calcification of matrix Gla protein-deficient mice: evidence for osteopontin as an inducible inhibitor of vascular calcification in vivo. J Exp Med 2002; 196:1047-55.
5. Steitz SA, Speer MY, McKee MD, et al. Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification. Am J Pathol 2002; 161:2035-46.
6. Patarca R, Freeman GJ, Singh RP, et al. Structural and functional studies of the early T lymphocyte activation 1 (Eta-1) gene. J Exp Med 1989; 170:145-61.
7. Ashkar S, Weber GF, Panoutsakopoulou V, et al. Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science 2000; 287:860-4.
8. Lampe MA, Patarca R, Iregui MV, Cantor H. Polyclonal B cell activation by the Eta-1 cytokine and the development of systemic autoimmune disease. J Immunol 1991; 147:2902-6.
9. Yamamoto N, Sakai F, Kon S, et al. Essential role of the cryptic epitope SLAYGLR within osteopontin in a murine model of rheumatoid arthritis. J Clin Invest 2003; 112:181-8.
10. Yumoto K, Ishijima M, Rittling SR, et al. Osteopontin deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice. Proc Natl Acad Sci USA 2002; 99:4556-61.
11. Chabas D, Baranzini SE, Mitchell D, et al. The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science 2001; 294:1731-5.
12. Iizuka J, Katagiri Y, Tada N, et al. Introduction of an osteopontin gene confers the increase in Bl cell population and the production of anti-DNA autoantibodies. Lab Invest 1998; 78:1523-33.
13. Patarca R, Wei F-Y, Singh P, Morasso MI, Cantor H. Dysregulated expression of the T cell cytokine Eta-1 in CD4 and CD8 lymphocytes during the development of murine autoimmune disease. J Exp Med 1990; 172:1177-83.
14. Li Q, Schacker T, Carlis J, Beilman G, Nguyen P, Haase AT. Functional genomic analysis of the response of HIV-1-infected lymphatic tissue to antiretroviral therapy. J Infect Dis 2004; 189:572-82.
15. Schacker TW, Nguyen PL, Beilman GJ, et al. Collagen deposition in HIV-1 infected lymphatic tissues and T cell homeostasis. J Clin Invest 2002; 110:1133-9.
16. Institute for Laboratory Animal Research. Guide for the care and use of laboratory animals. Washington, DC: National Academy Press, 1996.
17. Fedarko NS, Jain A, Karadag A, Van Eman MR, Fisher LW. Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer. Clin Cancer Res 2001; 7:4060-6.
18. Fisher LW, Torchia DA, Fohr B, Young MF, Fedarko NS. Flexible structures of SIBLING proteins, bone sialoprotein, and osteopontin. Biochem Biophys Res Commun 2001; 280:460-5.
19. Haase AT, Henry K, Zupanic M, et al. Quantitative image analysis of HIV-1 infection in lymphoid tissue. Science 1996; 274:985-9.
20. Weber GF, Cantor H. The immunology of Eta-1/osteopontin. Cytokine Growth Factor Rev 1996; 7:241-8.
21. Zhang Z-Q, Schuler T, Cavert W, et al. Reversibility of the pathological changes in the follicular dendritic cell network with treatment of HIV-1 infection. Proc Natl Acad Sci USA 1999; 96:5169-72.
22. Racz P, Tenner-Racz K, Kahl C, Feller A, Kern P, Dietrich M. Spectrum of morphologic changes of lymph nodes from patients with AIDS or AIDS-related complexes. Prog Allergy 1986; 37:81-181.
23. Chalifoux LV, Ringler DJ, King NW, et al. Lymphadenopathy in macaques experimentally infected with simian immunodeficiency virus (SIV). Am J Pathol 1987; 128:104-10.
24. Lane HC, Masur H, Edgar LC, Whalen G, Rook AH, Fauci AS. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med 1983; 309: 453-8.
25. Samuelsson A, Sonnorborg A, Heuts N, Coster J, Chiodi F. Progressive B cell apoptosis and expression of Fas ligand during human immunodeficiency virus type 1 infection. AIDS Res Hum Retroviruses 1997; 13:1031-8.
26. Shirai A, Cosentino M, Leitman-Klinman SF, Klinman DM. Human immunodeficiency virus infection induces both polyclonal and virus activation. J Clin Invest 1992; 89:561-6.
27. Zamarchi R, Barelli A, Borri A, et al. B cell activation in peripheral blood and lymph nodes during HIV infection. AIDS 2002; 16:1217-26.
28. Mestas J, Hughes CCW. Of mice and not men: differences between mouse and human immunology. J Immunol 2004; 172:2731-8.
29. Monroe JG, Silberstein LE. HIV-mediated B-lymphocyte activation and lymphomagenesis. J Clin Immunol 1995; 15:61-8.
30. Schnittman SM, Lane HC, Higgins SE, Folks T, Fauci AS. Direct polyclonal activation of human B lymphocytes by the acquired immune deficiency syndrome virus. Science 1986; 233:1084-6.
31. De Melito A, Nilsson A, Titanji K, et al. Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infection. Blood 2004; 103:2180-6.
32. O'Regan AW, Hayden JM, Berman JS. Osteopontin augments CD3-mediated interferon-γ and CD40 ligand expression by T cells, which results in IL-12 production from peripheral blood mononuclear cells. J Leukoc Biol 2000; 68:495-502.
33. Kiefer MC, Bauer DM, Barr PJ. The cDNA and derived amino acid sequence for human osteopontin. Nucleic Acids Res 1989; 17:3306.
34. Young MF, Kerr JM, Termine JD, et al. cDNA cloning, mRNA distribution and heterogeneity, chromosomal location, and RFLP analysis of human osteopontin (OPN). Genomics 1990; 7:491-502.
35. Fisher LW, Yopung MF, Kozak CA, Dixon MJ. Mapping of the human and mouse sialoprotein and osteopontin loci. Mamm Genome 1996; 7:149-51.
36. Zhang Z-Q, Wietgrefe SW, Li Q, et al. Roles of substrate availability and infection of resting and activated CD4+ T cells in transmission and acute simian immunodeficiency virus infection. Proc Natl Acad Sci USA 2004; 101:5640-5.